{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:01:01Z","timestamp":1785553261526,"version":"3.56.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Retina and optic nerve are sites of extra-cerebral manifestations of Alzheimer\u2019s Disease (AD). Amyloid-\u03b2 (A\u03b2) plaques and neurofibrillary tangles of hyperphosphorylated tau protein are detected in eyes from AD patients and transgenic animals in correlation with inflammation, reduction of synapses, visual deficits, loss of retinal cells and nerve fiber. However, neither the pathological relevance of other post-translational tau modifications\u2014such as truncation with generation of toxic fragments\u2014nor the potential neuroprotective action induced by their in vivo clearance have been investigated in the context of AD retinal degeneration. We have recently developed a monoclonal tau antibody (12A12mAb) which selectively targets the neurotoxic 20\u201322\u00a0kDa NH<jats:sub>2<\/jats:sub>-derived peptide generated from pathological truncation at the N-terminal domain of tau without cross-reacting with its full-length normal protein. Previous studies have shown that 12A12mAb, when intravenously (i.v.)-injected into 6-month-old Tg2576 animals, markedly improves their AD-like, behavioural and neuropathological syndrome. By taking advantage of this well-established tau-directed immunization regimen, we found that 12A12mAb administration also exerts a beneficial action on biochemical, morphological and metabolic parameters (i.e. APP\/A\u03b2 processing, tau hyperphosphorylation, neuroinflammation, synaptic proteins, microtubule stability, mitochondria-based energy production, neuronal death) associated with ocular injury in the AD phenotype. These findings prospect translational implications in the AD field by: (1) showing for the first time that cleavage of tau takes part in several pathological changes occurring in vivo in affected retinas and vitreous bodies and that its deleterious effects are successfully antagonized by administration of the specific 12A12mAb; (2) shedding further insights on the tight connections between neurosensory retina and brain, in particular following tau-based immunotherapy. In our view, the parallel response we detected in this preclinical animal model, both in the eye and in the hippocampus, following i.v. 12A12mAb injection opens novel diagnostic and therapeutic avenues for the clinical management of cerebral and extracerebral AD signs in human beings.<\/jats:p>","DOI":"10.1186\/s40478-021-01138-1","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T10:03:37Z","timestamp":1615284217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer\u2019s Disease"],"prefix":"10.1186","volume":"9","author":[{"given":"Valentina","family":"Latina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Giacovazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cordella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijorn Omar","family":"Balzamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Micera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Varano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Malerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Bruni","family":"Ercole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"La Regina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Atlante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Coccurello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Di Angelantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Calissano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2080-2951","authenticated-orcid":false,"given":"Giuseppina","family":"Amadoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"issue":"6","key":"1138_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","volume":"132","author":"NJ Hart","year":"2016","unstructured":"Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M (2016) Ocular indicators of Alzheimer\u2019s: exploring disease in the retina. Acta Neuropathol 132(6):767\u2013787. https:\/\/doi.org\/10.1007\/s00401-016-1613-6","journal-title":"Acta Neuropathol"},{"key":"1138_CR2","doi-asserted-by":"publisher","first-page":"8538573","DOI":"10.1155\/2018\/8538573","volume":"2018","author":"P Colligris","year":"2018","unstructured":"Colligris P, Perez de Lara MJ, Colligris B, Pintor J (2018) Ocular manifestations of Alzheimer\u2019s and other neurodegenerative diseases: the prospect of the eye as a tool for the early diagnosis of Alzheimer\u2019s Disease. J Ophthalmol 2018:8538573. https:\/\/doi.org\/10.1155\/2018\/8538573","journal-title":"J Ophthalmol"},{"issue":"1","key":"1138_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/1567205013666160819131904","volume":"14","author":"BT Reed","year":"2017","unstructured":"Reed BT, Behar-Cohen F, Krantic S (2017) Seeing early signs of Alzheimer\u2019s disease through the lens of the eye. Curr Alzheimer Res 14(1):6\u201317. https:\/\/doi.org\/10.2174\/1567205013666160819131904","journal-title":"Curr Alzheimer Res"},{"key":"1138_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2016.04.059","volume":"623","author":"VK Gupta","year":"2016","unstructured":"Gupta VK, Chitranshi N, Gupta VB, Golzan M, Dheer Y, Wall RV, Georgevsky D, King AE, Vickers JC, Chung R, Graham S (2016) Amyloid \u03b2 accumulation and inner retinal degenerative changes in Alzheimer\u2019s disease transgenic mouse. Neurosci Lett 623:52\u201356. https:\/\/doi.org\/10.1016\/j.neulet.2016.04.059","journal-title":"Neurosci Lett"},{"issue":"11","key":"1138_CR5","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1167\/iovs.08-1849","volume":"49","author":"A Ning","year":"2008","unstructured":"Ning A, Cui J, To E, Ashe KH, Matsubara J (2008) Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci 49(11):5136\u20135143. https:\/\/doi.org\/10.1167\/iovs.08-1849","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1138_CR6","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.2353\/ajpath.2009.090159","volume":"175","author":"B Liu","year":"2009","unstructured":"Liu B, Rasool S, Yang Z, Glabe CG, Schreiber SS, Ge J, Tan Z (2009) Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer\u2019s transgenic mice. Am J Pathol 175(5):2099\u20132110. https:\/\/doi.org\/10.2353\/ajpath.2009.090159","journal-title":"Am J Pathol"},{"issue":"3","key":"1138_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.neurobiolaging.2009.03.002","volume":"32","author":"L Gasparini","year":"2011","unstructured":"Gasparini L, Crowther RA, Martin KR, Berg N, Coleman M, Goedert M, Spillantini MG (2011) Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability. Neurobiol Aging 32(3):419\u2013433. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.03.002","journal-title":"Neurobiol Aging"},{"issue":"12","key":"1138_CR8","doi-asserted-by":"publisher","first-page":"e53547","DOI":"10.1371\/journal.pone.0053547","volume":"7","author":"C Sch\u00f6n","year":"2012","unstructured":"Sch\u00f6n C, Hoffmann NA, Ochs SM, Burgold S, Filser S, Steinbach S, Seeliger MW, Arzberger T, Goedert M, Kretzschmar HA, Schmidt B, Herms J (2012) Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS ONE 7(12):e53547. https:\/\/doi.org\/10.1371\/journal.pone.0053547","journal-title":"PLoS ONE"},{"issue":"9","key":"1138_CR9","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00417-009-1060-3","volume":"247","author":"RM Dutescu","year":"2009","unstructured":"Dutescu RM, Li QX, Crowston J, Masters CL, Baird PN, Culvenor JG (2009) Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer\u2019s disease. Graefes Arch Clin Exp Ophthalmol 247(9):1213\u20131221. https:\/\/doi.org\/10.1007\/s00417-009-1060-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"1138_CR10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1167\/iovs.08-2384","volume":"50","author":"SE Perez","year":"2009","unstructured":"Perez SE, Lumayag S, Kovacs B, Mufson EJ, Xu S (2009) Beta-amyloid deposition and functional impairment in the retina of the APPswe\/PS1DeltaE9 transgenic mouse model of Alzheimer\u2019s disease. Invest Ophthalmol Vis Sci 50(2):793\u2013800. https:\/\/doi.org\/10.1167\/iovs.08-2384","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"1138_CR11","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL (2011) Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54(Suppl 1):S204\u2013S217. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.020","journal-title":"Neuroimage"},{"key":"1138_CR12","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-191346","author":"U Habiba","year":"2020","unstructured":"Habiba U, Merlin S, Lim JKH, Wong VHY, Nguyen CTO, Morley JW, Bui BV, Tayebi M (2020) Age-specific retinal and cerebral immunodetection of amyloid-\u03b2 plaques and oligomers in a rodent model of Alzheimer\u2019s Disease. J Alzheimers Dis. https:\/\/doi.org\/10.3233\/JAD-191346","journal-title":"J Alzheimers Dis"},{"key":"1138_CR13","doi-asserted-by":"publisher","first-page":"100899","DOI":"10.1016\/j.preteyeres.2020.100899","volume":"2020","author":"VB Gupta","year":"2020","unstructured":"Gupta VB, Chitranshi N, den Haan J, Mirzaei M, You Y, Lim JK, Basavarajappa D, Godinez A, Di Angelantonio S, Sachdev P, Salekdeh GH, Bouwman F, Graham S, Gupta V (2020) Retinal changes in Alzheimer\u2019s disease-integrated prospects of imaging, functional and molecular advances. Prog Retin Eye Res 2020:100899. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100899","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"1138_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/156720510790274491","volume":"7","author":"L Guo","year":"2010","unstructured":"Guo L, Duggan J, Cordeiro MF (2010) Alzheimer\u2019s disease and retinal neurodegeneration. Curr Alzheimer Res 7(1):3\u201314. https:\/\/doi.org\/10.2174\/156720510790274491","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"1138_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40478-018-0650-x","volume":"6","author":"J den Haan","year":"2018","unstructured":"den Haan J, Morrema THJ, Verbraak FD, de Boer JF, Scheltens P, Rozemuller AJ, Bergen AAB, Bouwman FH, Hoozemans JJ (2018) Amyloid-beta and phosphorylated tau in post-mortem Alzheimer\u2019s disease retinas. Acta Neuropathol Commun 6(1):147. https:\/\/doi.org\/10.1186\/s40478-018-0650-x","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"1138_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s11357-011-9260-2","volume":"34","author":"K Chiu","year":"2012","unstructured":"Chiu K, Chan TF, Wu A, Leung IY, So KF, Chang RC (2012) Neurodegeneration of the retina in mouse models of Alzheimer\u2019s disease: what can we learn from the retina? Age (Dordr) 34(3):633\u2013649. https:\/\/doi.org\/10.1007\/s11357-011-9260-2","journal-title":"Age (Dordr)"},{"key":"1138_CR17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fnins.2019.00925","volume":"13","author":"A Grimaldi","year":"2019","unstructured":"Grimaldi A, Pediconi N, Oieni F, Pizzarelli R, Rosito M, Giubettini M, Santini T, Limatola C, Ruocco G, Ragozzino D, Di Angelantonio S (2019) Neuroinflammatory processes, A1 astrocyte activation and protein aggregation in the retina of Alzheimer\u2019s disease patients, possible biomarkers for early diagnosis. Front Neurosci 13:925. https:\/\/doi.org\/10.3389\/fnins.2019.00925","journal-title":"Front Neurosci"},{"issue":"8","key":"1138_CR18","doi-asserted-by":"publisher","first-page":"e668","DOI":"10.1111\/aos.13319","volume":"95","author":"Y Kusne","year":"2017","unstructured":"Kusne Y, Wolf AB, Townley K, Conway M, Peyman GA (2017) Visual system manifestations of Alzheimer\u2019s disease. Acta Ophthalmol 95(8):e668\u2013e676. https:\/\/doi.org\/10.1111\/aos.13319","journal-title":"Acta Ophthalmol"},{"key":"1138_CR19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3389\/fnins.2020.00921","volume":"14","author":"N Mirzaei","year":"2020","unstructured":"Mirzaei N, Shi H, Oviatt M, Doustar J, Rentsendorj A, Fuchs DT, Sheyn J, Black K, Koronyo Y, Koronyo-Hamaoui M (2020) Alzheimer\u2019s retinopathy: seeing disease in the eyes. Front Neurosci 14:921. https:\/\/doi.org\/10.3389\/fnins.2020.00921","journal-title":"Front Neurosci"},{"issue":"11","key":"1138_CR20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2174\/1567205013666160603003800","volume":"13","author":"S Frost","year":"2016","unstructured":"Frost S, Guymer R, Aung KZ, Macaulay SL, Sohrabi HR, Bourgeat P, Salvado O, Rowe CC, Ames D, Masters CL, Martins RN, Kanagasingam Y, AIBL Research Group (2016) Alzheimer\u2019s Disease and the early signs of age-related macular degeneration. Curr Alzheimer Res 13(11):1259\u20131266. https:\/\/doi.org\/10.2174\/1567205013666160603003800","journal-title":"Curr Alzheimer Res"},{"issue":"8","key":"1138_CR21","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/s0028-3932(00)00023-3","volume":"38","author":"M Rizzo","year":"2000","unstructured":"Rizzo M, Anderson SW, Dawson J, Nawrot M (2000) Vision and cognition in Alzheimer\u2019s disease. Neuropsychologia 38(8):1157\u20131169. https:\/\/doi.org\/10.1016\/s0028-3932(00)00023-3","journal-title":"Neuropsychologia"},{"issue":"3","key":"1138_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/00006324-199503000-00004","volume":"72","author":"A Cronin-Golomb","year":"1995","unstructured":"Cronin-Golomb A, Corkin S, Growdon JH (1995) Visual dysfunction predicts cognitive deficits in Alzheimer\u2019s disease. Optom Vis Sci 72(3):168\u2013176. https:\/\/doi.org\/10.1097\/00006324-199503000-00004","journal-title":"Optom Vis Sci"},{"key":"1138_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1159\/isbn.978-3-318-01091-6","volume-title":"Vision in Alzheimer's disease","author":"A Cronin-Golomb","year":"2004","unstructured":"Cronin-Golomb A (2004) Heterogeneity of visual presentation in Alzheimer\u2019s disease . In: Gronin-Golomb A, Hof P (eds) Vision in Alzheimer\u2019s disease. Karger, Switzerland, pp 370\u2013376"},{"issue":"7","key":"1138_CR24","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/s0010-9452(08)70693-2","volume":"43","author":"A Cronin-Golomb","year":"2007","unstructured":"Cronin-Golomb A, Gilmore GC, Neargarder S, Morrison SR, Laudate TM (2007) Enhanced stimulus strength improves visual cognition in aging and Alzheimer\u2019s disease. Cortex 43(7):952\u2013966. https:\/\/doi.org\/10.1016\/s0010-9452(08)70693-2","journal-title":"Cortex"},{"issue":"8","key":"1138_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM198608213150804","volume":"315","author":"DR Hinton","year":"1986","unstructured":"Hinton DR, Sadun AA, Blanks JC, Miller CA (1986) Optic-nerve degeneration in Alzheimer\u2019s disease. N Engl J Med 315(8):485\u2013487. https:\/\/doi.org\/10.1056\/NEJM198608213150804","journal-title":"N Engl J Med"},{"issue":"2","key":"1138_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.410260207","volume":"26","author":"B Katz","year":"1989","unstructured":"Katz B, Rimmer S, Iragui V, Katzman R (1989) Abnormal pattern electroretinogram in Alzheimer\u2019s disease: evidence for retinal ganglion cell degeneration? Ann Neurol 26(2):221\u2013225. https:\/\/doi.org\/10.1002\/ana.410260207","journal-title":"Ann Neurol"},{"issue":"3","key":"1138_CR27","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0733-8619(02)00107-x","volume":"21","author":"GR Jackson","year":"2003","unstructured":"Jackson GR, Owsley C (2003) Visual dysfunction, neurodegenerative diseases, and aging. Neurol Clin 21(3):709\u2013728. https:\/\/doi.org\/10.1016\/s0733-8619(02)00107-x","journal-title":"Neurol Clin"},{"issue":"2","key":"1138_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0161-6420(03)00732-2","volume":"111","author":"AG Lee","year":"2004","unstructured":"Lee AG, Martin CO (2004) Neuro-ophthalmic findings in the visual variant of Alzheimer\u2019s disease. Ophthalmology 111(2):376\u2013380. https:\/\/doi.org\/10.1016\/S0161-6420(03)00732-2","journal-title":"Ophthalmology"},{"issue":"1","key":"1138_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.wno.0000204645.56873.26","volume":"26","author":"PK Iseri","year":"2006","unstructured":"Iseri PK, Altina\u015f O, Tokay T, Y\u00fcksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26(1):18\u201324 (discussion 380\u20131). https:\/\/doi.org\/10.1097\/01.wno.0000204645.56873.26","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"1138_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/bf02598307","volume":"6","author":"RF Uhlmann","year":"1991","unstructured":"Uhlmann RF, Larson EB, Koepsell TD, Rees TS, Duckert LG (1991) Visual impairment and cognitive dysfunction in Alzheimer\u2019s disease. J Gen Intern Med 6(2):126\u2013132. https:\/\/doi.org\/10.1007\/bf02598307","journal-title":"J Gen Intern Med"},{"issue":"3","key":"1138_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00006324-199503000-00003","volume":"72","author":"JD Mendola","year":"1995","unstructured":"Mendola JD, Cronin-Golomb A, Corkin S, Growdon JH (1995) Prevalence of visual deficits in Alzheimer\u2019s disease. Optom Vis Sci 72(3):155\u2013167. https:\/\/doi.org\/10.1097\/00006324-199503000-00003","journal-title":"Optom Vis Sci"},{"issue":"1","key":"1138_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1212\/wnl.45.1.68","volume":"45","author":"GL Trick","year":"1995","unstructured":"Trick GL, Trick LR, Morris P, Wolf M (1995) Visual field loss in senile dementia of the Alzheimer\u2019s type. Neurology 45(1):68\u201374. https:\/\/doi.org\/10.1212\/wnl.45.1.68","journal-title":"Neurology"},{"issue":"1","key":"1138_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1176\/ajp.153.1.32","volume":"153","author":"MJ Mentis","year":"1996","unstructured":"Mentis MJ, Horwitz B, Grady CL, Alexander GE, VanMeter JW, Maisog JM, Pietrini P, Schapiro MB, Rapoport SI (1996) Visual cortical dysfunction in Alzheimer\u2019s disease evaluated with a temporally graded \u201cstress test\u201d during PET. Am J Psychiatry 153(1):32\u201340. https:\/\/doi.org\/10.1176\/ajp.153.1.32","journal-title":"Am J Psychiatry"},{"issue":"6","key":"1138_CR34","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00005072-200606000-00010","volume":"65","author":"AC McKee","year":"2006","unstructured":"McKee AC, Au R, Cabral HJ, Kowall NW, Seshadri S, Kubilus CA, Drake J, Wolf PA (2006) Visual association pathology in preclinical Alzheimer disease. J Neuropathol Exp Neurol 65(6):621\u2013630. https:\/\/doi.org\/10.1097\/00005072-200606000-00010","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"1138_CR35","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1167\/iovs.06-1029","volume":"48","author":"F Berisha","year":"2007","unstructured":"Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL (2007) Retinal abnormalities in early Alzheimer\u2019s disease. Invest Ophthalmol Vis Sci 48(5):2285\u20132289. https:\/\/doi.org\/10.1167\/iovs.06-1029","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"1138_CR36","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/aos.14121","volume":"97","author":"JA van de Kreeke","year":"2019","unstructured":"van de Kreeke JA, Nguyen HT, den Haan J, Konijnenberg E, Tomassen J, den Braber A, Ten Kate M, Collij L, Yaqub M, van Berckel B, Lammertsma AA, Boomsma DI, Tan HS, Verbraak FD, Visser PJ (2019) Retinal layer thickness in preclinical Alzheimer\u2019s disease. Acta Ophthalmol 97(8):798\u2013804. https:\/\/doi.org\/10.1111\/aos.14121","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"1138_CR37","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1001\/jamaneurol.2018.1563","volume":"75","author":"U Mutlu","year":"2018","unstructured":"Mutlu U, Colijn JM, Ikram MA, Bonnemaijer PWM, Licher S, Wolters FJ, Tiemeier H, Koudstaal PJ, Klaver CCW, Ikram MK (2018) Association of retinal neurodegeneration on optical coherence tomography with dementia: a population-based study. JAMA Neurol 75(10):1256\u20131263. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1563","journal-title":"JAMA Neurol"},{"issue":"7","key":"1138_CR38","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2174\/156720512802455340","volume":"9","author":"MM Moschos","year":"2012","unstructured":"Moschos MM, Markopoulos I, Chatziralli I, Rouvas A, Papageorgiou SG, Ladas I, Vassilopoulos D (2012) Structural and functional impairment of the retina and optic nerve in Alzheimer\u2019s disease. Curr Alzheimer Res 9(7):782\u2013788. https:\/\/doi.org\/10.2174\/156720512802455340","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"1138_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3233\/JAD-150939","volume":"53","author":"T Yamasaki","year":"2016","unstructured":"Yamasaki T, Horie S, Ohyagi Y, Tanaka E, Nakamura N, Goto Y, Kanba S, Kira J, Tobimatsu S (2016) A potential VEP biomarker for mild cognitive impairment: evidence from selective visual deficit of higher-level dorsal pathway. J Alzheimers Dis 53(2):661\u2013676. https:\/\/doi.org\/10.3233\/JAD-150939","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1138_CR40","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1212\/01.wnl.0000049471.76799.de","volume":"60","author":"M Mapstone","year":"2003","unstructured":"Mapstone M, Steffenella TM, Duffy CJ (2003) A visuospatial variant of mild cognitive impairment: getting lost between aging and AD. Neurology 60(5):802\u2013808. https:\/\/doi.org\/10.1212\/01.wnl.0000049471.76799.de","journal-title":"Neurology"},{"issue":"1","key":"1138_CR41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2010.06.006","volume":"480","author":"Y Lu","year":"2010","unstructured":"Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, Ma D (2010) Retinal nerve fiber layer structure abnormalities in early Alzheimer\u2019s disease: evidence in optical coherence tomography. Neurosci Lett 480(1):69\u201372. https:\/\/doi.org\/10.1016\/j.neulet.2010.06.006","journal-title":"Neurosci Lett"},{"issue":"2","key":"1138_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jalz.2013.06.009","volume":"10","author":"CY Cheung","year":"2014","unstructured":"Cheung CY, Ong YT, Ikram MK, Ong SY, Li X, Hilal S, Catindig JA, Venketasubramanian N, Yap P, Seow D, Chen CP, Wong TY (2014) Microvascular network alterations in the retina of patients with Alzheimer\u2019s disease. Alzheimers Dement 10(2):135\u2013142. https:\/\/doi.org\/10.1016\/j.jalz.2013.06.009","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1138_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s40478-020-01076-4","volume":"8","author":"H Shi","year":"2020","unstructured":"Shi H, Koronyo Y, Fuchs DT, Sheyn J, Wawrowsky K, Lahiri S, Black KL, Koronyo-Hamaoui M (2020) Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer\u2019s disease. Acta Neuropathol Commun 8(1):202. https:\/\/doi.org\/10.1186\/s40478-020-01076-4","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"1138_CR44","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00401-020-02134-w","volume":"139","author":"H Shi","year":"2020","unstructured":"Shi H, Koronyo Y, Rentsendorj A, Regis GC, Sheyn J, Fuchs DT, Kramerov AA, Ljubimov AV, Dumitrascu OM, Rodriguez AR, Barron E, Hinton DR, Black KL, Miller CA, Mirzaei N, Koronyo-Hamaoui M (2020) Identification of early pericyte loss and vascular amyloidosis in Alzheimer\u2019s disease retina. Acta Neuropathol 139(5):813\u2013836. https:\/\/doi.org\/10.1007\/s00401-020-02134-w","journal-title":"Acta Neuropathol"},{"key":"1138_CR45","doi-asserted-by":"publisher","first-page":"6248185","DOI":"10.1155\/2019\/6248185","volume":"2019","author":"QZ Ngoo","year":"2019","unstructured":"Ngoo QZ, Hitam WHW, Razak AA (2019) Evaluation of retinal nerve fiber layer thickness, electroretinogram and visual evoked potential in patients with Alzheimer\u2019s disease. J Ophthalmol 2019:6248185. https:\/\/doi.org\/10.1155\/2019\/6248185","journal-title":"J Ophthalmol"},{"key":"1138_CR46","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fnins.2016.00536","volume":"10","author":"JK Lim","year":"2016","unstructured":"Lim JK, Li QX, He Z, Vingrys AJ, Wong VH, Currier N, Mullen J, Bui BV, Nguyen CT (2016) The eye as a biomarker for Alzheimer\u2019s disease. Front Neurosci 10:536. https:\/\/doi.org\/10.3389\/fnins.2016.00536","journal-title":"Front Neurosci"},{"issue":"16","key":"1138_CR47","doi-asserted-by":"publisher","first-page":"93621","DOI":"10.1172\/jci.insight.93621","volume":"2","author":"Y Koronyo","year":"2017","unstructured":"Koronyo Y, Biggs D, Barron E, Boyer DS, Pearlman JA, Au WJ, Kile SJ, Blanco A, Fuchs DT, Ashfaq A, Frautschy S, Cole GM, Miller CA, Hinton DR, Verdooner SR, Black KL, Koronyo-Hamaoui M (2017) Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight 2(16):93621. https:\/\/doi.org\/10.1172\/jci.insight.93621","journal-title":"JCI Insight"},{"issue":"1\u20134","key":"1138_CR48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000335154","volume":"10","author":"Y Koronyo","year":"2012","unstructured":"Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M (2012) Alzheimer\u2019s disease in the retina: imaging retinal a\u03b2 plaques for early diagnosis and therapy assessment. Neurodegener Dis 10(1\u20134):285\u2013293. https:\/\/doi.org\/10.1159\/000335154","journal-title":"Neurodegener Dis"},{"issue":"3 Pt 1","key":"1138_CR49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/wnl.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology 42(3 Pt 1):631\u2013639. https:\/\/doi.org\/10.1212\/wnl.42.3.631","journal-title":"Neurology"},{"issue":"9","key":"1138_CR50","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/01.wnl.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos P, Herrmann FR, Bussi\u00e8re T, Bouras C, K\u00f6vari E, Perl DP, Morrison JH, Gold G, Hof PR (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease. Neurology 60(9):1495\u20131500. https:\/\/doi.org\/10.1212\/01.wnl.0000063311.58879.01","journal-title":"Neurology"},{"issue":"3","key":"1138_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.mcn.2008.03.011","volume":"38","author":"V Corsetti","year":"2008","unstructured":"Corsetti V, Amadoro G, Gentile A, Capsoni S, Ciotti MT, Cencioni MT, Atlante A, Canu N, Rohn TT, Cattaneo A, Calissano P (2008) Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer\u2019s disease models. Mol Cell Neurosci 38(3):381\u2013392. https:\/\/doi.org\/10.1016\/j.mcn.2008.03.011","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"1138_CR52","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3233\/JAD-2010-100120","volume":"21","author":"G Amadoro","year":"2010","unstructured":"Amadoro G, Corsetti V, Stringaro A, Colone M, D\u2019Aguanno S, Meli G, Ciotti M, Sancesario G, Cattaneo A, Bussani R, Mercanti D, Calissano P (2010) A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration. J Alzheimers Dis 21(2):445\u2013470. https:\/\/doi.org\/10.3233\/JAD-2010-100120","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1138_CR53","doi-asserted-by":"publisher","first-page":"833.e1","DOI":"10.1016\/j.neurobiolaging.2011.08.001","volume":"33","author":"G Amadoro","year":"2012","unstructured":"Amadoro G, Corsetti V, Atlante A, Florenzano F, Capsoni S, Bussani R, Mercanti D, Calissano P (2012) Interaction between NH(2)-tau fragment and A\u03b2 in Alzheimer\u2019s disease mitochondria contributes to the synaptic deterioration. Neurobiol Aging 33(4):833.e1\u201325. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.08.001","journal-title":"Neurobiol Aging"},{"issue":"11","key":"1138_CR54","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/hmg\/ddv059","volume":"24","author":"V Corsetti","year":"2015","unstructured":"Corsetti V, Florenzano F, Atlante A, Bobba A, Ciotti MT, Natale F, Della Valle F, Borreca A, Manca A, Meli G, Ferraina C, Feligioni M, D\u2019Aguanno S, Bussani R, Ammassari-Teule M, Nicolin V, Calissano P, Amadoro G (2015) NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer\u2019s disease. Hum Mol Genet 24(11):3058\u20133081. https:\/\/doi.org\/10.1093\/hmg\/ddv059","journal-title":"Hum Mol Genet"},{"issue":"39","key":"1138_CR55","doi-asserted-by":"publisher","first-page":"64745","DOI":"10.18632\/oncotarget.17371","volume":"8","author":"F Florenzano","year":"2017","unstructured":"Florenzano F, Veronica C, Ciasca G, Ciotti MT, Pittaluga A, Olivero G, Feligioni M, Iannuzzi F, Latina V, Maria Sciacca MF, Sinopoli A, Milardi D, Pappalardo G, Marco S, Papi M, Atlante A, Bobba A, Borreca A, Calissano P, Amadoro G (2017) Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer\u2019s disease and other tauopathies. Oncotarget 8(39):64745\u201364778. https:\/\/doi.org\/10.18632\/oncotarget.17371","journal-title":"Oncotarget"},{"issue":"10","key":"1138_CR56","doi-asserted-by":"publisher","first-page":"8124","DOI":"10.1007\/s12035-018-0974-3","volume":"55","author":"A Borreca","year":"2018","unstructured":"Borreca A, Latina V, Corsetti V, Middei S, Piccinin S, Della Valle F, Bussani R, Ammassari-Teule M, Nistic\u00f2 R, Calissano P, Amadoro G (2018) AD-Related N-terminal truncated tau is sufficient to recapitulate in vivo the early perturbations of human neuropathology: implications for immunotherapy. Mol Neurobiol 55(10):8124\u20138153. https:\/\/doi.org\/10.1007\/s12035-018-0974-3","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1138_CR57","doi-asserted-by":"publisher","first-page":"fcaa039","DOI":"10.1093\/braincomms\/fcaa039","volume":"2","author":"V Corsetti","year":"2020","unstructured":"Corsetti V, Borreca A, Latina V, Giacovazzo G, Pignataro A, Krashia P, Natale F, Cocco S, Rinaudo M, Malerba F, Florio R, Ciarapica R, Coccurello R, D\u2019Amelio M, Ammassari-Teule M, Grassi C, Calissano P, Amadoro G (2020) Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer\u2019s disease models. Brain Commun 2(1):fcaa039. https:\/\/doi.org\/10.1093\/braincomms\/fcaa039","journal-title":"Brain Commun"},{"issue":"12","key":"1138_CR58","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/WNR.0b013e3283497334","volume":"22","author":"PN Alexandrov","year":"2011","unstructured":"Alexandrov PN, Pogue A, Bhattacharjee S, Lukiw WJ (2011) Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer\u2019s disease. NeuroReport 22(12):623\u2013627. https:\/\/doi.org\/10.1097\/WNR.0b013e3283497334","journal-title":"NeuroReport"},{"issue":"1","key":"1138_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, YounkinS YF, Cole G (1996) Correlative memory deficits, A\u03b2 elevation, and amyloid plaques in transgenic mice. Science 274(1):99\u2013102. https:\/\/doi.org\/10.1126\/science.274.5284.99","journal-title":"Science"},{"issue":"12","key":"1138_CR60","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1523\/JNEUROSCI.4989-14.2015","volume":"35","author":"DL Castillo-Carranza","year":"2015","unstructured":"Castillo-Carranza DL, Guerrero-Mu\u00f1oz MJ, Sengupta U, Hernandez C, Barrett AD, Dineley K, Kayed R (2015) Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer\u2019s disease mouse model. J Neurosci 35(12):4857\u20134868. https:\/\/doi.org\/10.1523\/JNEUROSCI.4989-14.2015","journal-title":"J Neurosci"},{"issue":"11","key":"1138_CR61","doi-asserted-by":"publisher","first-page":"e82140","DOI":"10.1371\/journal.pone.0082140","volume":"8","author":"JM Skeie","year":"2013","unstructured":"Skeie JM, Mahajan VB (2013) Proteomic interactions in the mouse vitreous-retina complex. PLoS ONE 8(11):e82140. https:\/\/doi.org\/10.1371\/journal.pone.0082140","journal-title":"PLoS ONE"},{"issue":"3","key":"1138_CR62","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12017-015-8360-z","volume":"17","author":"BO Balzamino","year":"2015","unstructured":"Balzamino BO, Esposito G, Marino R, Keller F, Micera A (2015) NGF expression in reelin-deprived retinal cells: a potential neuroprotective effect. Neuromol Med 17(3):314\u2013325. https:\/\/doi.org\/10.1007\/s12017-015-8360-z","journal-title":"Neuromol Med"},{"issue":"1","key":"1138_CR63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-017-0199-3","volume":"12","author":"M Chiasseu","year":"2017","unstructured":"Chiasseu M, Alarcon-Martinez L, Belforte N, Quintero H, Dotigny F, Destroismaisons L, Vande Velde C, Panayi F, Louis C, Di Polo A (2017) Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener 12(1):58. https:\/\/doi.org\/10.1186\/s13024-017-0199-3","journal-title":"Mol Neurodegener"},{"issue":"2","key":"1138_CR64","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/nbdi.2002.0549","volume":"11","author":"TT Rohn","year":"2002","unstructured":"Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E (2002) Caspase-9 activation and caspase cleavage of tau in the Alzheimer\u2019s disease brain. Neurobiol Dis 11(2):341\u2013354. https:\/\/doi.org\/10.1006\/nbdi.2002.0549","journal-title":"Neurobiol Dis"},{"key":"1138_CR65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mito.2014.10.005","volume":"20","author":"AM D'Erchia","year":"2015","unstructured":"D\u2019Erchia AM, Atlante A, Gadaleta G, Pavesi G, Chiara M, De Virgilio C, Manzari C, Mastropasqua F, Prazzoli GM, Picardi E et al (2015) Tissue-specific mtDNA abundance from exome data and its correlation with mitochondrial transcription, mass and respiratory activity. Mitochondrion 20:13\u201321. https:\/\/doi.org\/10.1016\/j.mito.2014.10.005","journal-title":"Mitochondrion"},{"key":"1138_CR66","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.bbabio.2008.07.004","volume":"1777","author":"A Atlante","year":"2008","unstructured":"Atlante A, Amadoro G, Bobba A, de Bari L, Corsetti V, Pappalardo G, Marra E, Calissano P, Passarella S (2008) A peptide containing residues 26\u201344 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator. Biochim Biophys Acta 1777:1289\u20131300. https:\/\/doi.org\/10.1016\/j.bbabio.2008.07.004","journal-title":"Biochim Biophys Acta"},{"key":"1138_CR67","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.mito.2013.03.008","volume":"13","author":"A Bobba","year":"2013","unstructured":"Bobba A, Amadoro G, Valenti D, Corsetti V, Lassandro R, Atlante A (2013) Mitochondrial respiratory chain Complexes I and IV are impaired by beta-amyloid via directinteraction and through Complex I-dependent ROS production, respectively. Mitochondrion 13:298\u2013311. https:\/\/doi.org\/10.1016\/j.mito.2013.03.008","journal-title":"Mitochondrion"},{"key":"1138_CR68","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/jmg.2003.014316","volume":"41","author":"P B\u00e9nit","year":"2004","unstructured":"B\u00e9nit P, Slama A, Cartault F, Giurgea I, Chretien D, Lebon S, Marsac C, Munnich A, R\u00f6tig A, Rustin P (2004) Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome. J Med Genet 41:14\u201317. https:\/\/doi.org\/10.1136\/jmg.2003.014316","journal-title":"J Med Genet"},{"key":"1138_CR69","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/BF02705114","volume":"28","author":"HA Khan","year":"2003","unstructured":"Khan HA (2003) Bioluminometric assay of ATP in mouse brain: determinant factors for enhanced test sensitivity. J Biosci 28:379\u2013382. https:\/\/doi.org\/10.1007\/BF02705114","journal-title":"J Biosci"},{"key":"1138_CR70","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1042\/BJ20100581","volume":"431","author":"D Valenti","year":"2010","unstructured":"Valenti D, Tullo A, Caratozzolo MF, Merafina RS, Scartezzini P, Marra E, Vacca RA (2010) Impairment of F1F0-ATPase, adenine nucleotide translocator and adenylate kinase causes mitochondrial energy deficit in human skin fibroblasts with chromosome 21 trisomy. Biochem J 431:299\u2013310. https:\/\/doi.org\/10.1042\/BJ20100581","journal-title":"Biochem J"},{"issue":"1","key":"1138_CR71","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-170959","volume":"63","author":"JP Quinn","year":"2018","unstructured":"Quinn JP, Corbett NJ, Kellett KAB, Hooper NM (2018) Tau proteolysis in the pathogenesis of tauopathies: neurotoxic fragments and novel biomarkers. J Alzheimers Dis 63(1):13\u201333. https:\/\/doi.org\/10.3233\/JAD-170959","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"1138_CR72","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.neurobiolaging.2013.01.006","volume":"34","author":"PA Williams","year":"2013","unstructured":"Williams PA, Thirgood RA, Oliphant H, Frizzati A, Littlewood E, Votruba M, Good MA, Williams J, Morgan JE (2013) Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging 34(7):1799\u20131806. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.01.006","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1138_CR73","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/jnc.12991","volume":"133","author":"S Sokolow","year":"2015","unstructured":"Sokolow S, Henkins KM, Bilousova T, Gonzalez B, Vinters HV, Miller CA, Cornwell L, Poon WW, Gylys KH (2015) Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer\u2019s disease. J Neurochem 133(3):368\u2013379. https:\/\/doi.org\/10.1111\/jnc.12991","journal-title":"J Neurochem"},{"issue":"4","key":"1138_CR74","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3233\/JAD-2010-100210","volume":"20","author":"A Prakasam","year":"2010","unstructured":"Prakasam A, Muthuswamy A, Ablonczy Z, Greig NH, Fauq A, Rao KJ, Pappolla MA, Sambamurti K (2010) Differential accumulation of secreted AbetaPP metabolites in ocular fluids. J Alzheimers Dis 20(4):1243\u20131253. https:\/\/doi.org\/10.3233\/JAD-2010-100210","journal-title":"J Alzheimers Dis"},{"key":"1138_CR75","first-page":"2700","volume":"18","author":"WL Ho","year":"2012","unstructured":"Ho WL, Leung Y, Tsang AW, So KF, Chiu K, Chang RC (2012) Review: tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain? Mol Vis 18:2700\u20132710","journal-title":"Mol Vis"},{"issue":"4","key":"1138_CR76","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3233\/JAD-181104","volume":"68","author":"LM Wright","year":"2019","unstructured":"Wright LM, Stein TD, Jun G, Chung J, McConnell K, Fiorello M, Siegel N, Ness S, Xia W, Turner KL, Subramanian ML (2019) Association of cognitive function with amyloid-\u03b2 and tau proteins in the vitreous humor. J Alzheimers Dis 68(4):1429\u20131438. https:\/\/doi.org\/10.3233\/JAD-181104","journal-title":"J Alzheimers Dis"},{"key":"1138_CR77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neulet.2013.06.026","volume":"551","author":"H Zhao","year":"2013","unstructured":"Zhao H, Chang R, Che H, Wang J, Yang L, Fang W, Xia Y, Li N, Ma Q, Wang X (2013) Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer\u2019s disease transgenic mouse. Neurosci Lett 551:12\u201316. https:\/\/doi.org\/10.1016\/j.neulet.2013.06.026","journal-title":"Neurosci Lett"},{"issue":"3","key":"1138_CR78","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3233\/JAD-160912","volume":"55","author":"AN Nilson","year":"2017","unstructured":"Nilson AN, English KC, Gerson JE, Barton Whittle T, Nicolas Crain C, Xue J, Sengupta U, Castillo-Carranza DL, Zhang W, Gupta P, Kayed R (2017) Tau oligomers associate with inflammation in the brain and retina of tauopathy mice and in neurodegenerative diseases. J Alzheimers Dis 55(3):1083\u20131099. https:\/\/doi.org\/10.3233\/JAD-160912","journal-title":"J Alzheimers Dis"},{"key":"1138_CR79","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.lfs.2014.12.019","volume":"124","author":"WL Ho","year":"2015","unstructured":"Ho WL, Leung Y, Cheng SS, Lok CK, Ho YS, Baum L, Yang X, Chiu K, Chang RC (2015) Investigating degeneration of the retina in young and aged tau P301L mice. Life Sci 124:16\u201323. https:\/\/doi.org\/10.1016\/j.lfs.2014.12.019","journal-title":"Life Sci"},{"issue":"47","key":"1138_CR80","doi-asserted-by":"publisher","first-page":"83038","DOI":"10.18632\/oncotarget.19886","volume":"8","author":"L Buccarello","year":"2017","unstructured":"Buccarello L, Sclip A, Sacchi M, Castaldo AM, Bertani I, ReCecconi A, Maestroni S, Zerbini G, Nucci P, Borsello T (2017) The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies. Oncotarget 8(47):83038\u201383051. https:\/\/doi.org\/10.18632\/oncotarget.19886","journal-title":"Oncotarget"},{"issue":"28","key":"1138_CR81","doi-asserted-by":"publisher","first-page":"E279","DOI":"10.1073\/pnas.1100901108","volume":"108","author":"JD Ding","year":"2011","unstructured":"Ding JD, Johnson LV, Herrmann R, Farsiu S, Smith SG, Groelle M, Mace BE, Sullivan P, Jamison JA, Kelly U, Harrabi O, Bollini SS, Dilley J, Kobayashi D, Kuang B, Li W, Pons J, Lin JC, Bowes RC (2011) Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A 108(28):E279\u2013E287. https:\/\/doi.org\/10.1073\/pnas.1100901108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1138_CR82","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1471-4159.2008.05606.x","volume":"107","author":"M Shimazawa","year":"2008","unstructured":"Shimazawa M, Inokuchi Y, Okuno T, Nakajima Y, Sakaguchi G, Kato A, Oku H, Sugiyama T, Kudo T, Ikeda T, Takeda M, Hara H (2008) Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling. J Neurochem 107(1):279\u2013290. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05606.x","journal-title":"J Neurochem"},{"issue":"5","key":"1138_CR83","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/jad-2002-4508","volume":"4","author":"C Otth","year":"2002","unstructured":"Otth C, Concha II, Arendt T, Stieler J, Schliebs R, Gonz\u00e1lez-Billault C, Maccioni RB (2002) AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis 4(5):417\u2013430. https:\/\/doi.org\/10.3233\/jad-2002-4508","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1138_CR84","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0304-3940(00)01767-5","volume":"299","author":"Y Tomidokoro","year":"2001","unstructured":"Tomidokoro Y, Ishiguro K, Harigaya Y, Matsubara E, Ikeda M, Park JM, Yasutake K, Kawarabayashi T, Okamoto K, Shoji M (2001) Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice. Neurosci Lett 299(3):169\u2013172. https:\/\/doi.org\/10.1016\/s0304-3940(00)01767-5","journal-title":"Neurosci Lett"},{"issue":"4","key":"1138_CR85","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/path.897","volume":"194","author":"Y Tomidokoro","year":"2001","unstructured":"Tomidokoro Y, Harigaya Y, Matsubara E, Ikeda M, Kawarabayashi T, Shirao T, Ishiguro K, Okamoto K, Younkin SG, Shoji M (2001) Brain Abeta amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau. J Pathol 194(4):500\u2013506. https:\/\/doi.org\/10.1002\/path.897","journal-title":"J Pathol"},{"key":"1138_CR86","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1138_CR87","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/j.1460-2075.1992.tb05204.x","volume":"11","author":"J Biernat","year":"1992","unstructured":"Biernat J, Mandelkow EM, Schr\u00f6ter C, Lichtenberg-Kraag B, Steiner B, Berling B, Meyer H, Mercken M, Vandermeeren A, Goedert M, Mandelkow E (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J 11(4):1593\u20131597","journal-title":"EMBO J"},{"issue":"6","key":"1138_CR88","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2174\/1389450043345236","volume":"5","author":"F Chen","year":"2004","unstructured":"Chen F, David D, Ferrari A, G\u00f6tz J (2004) Posttranslational modifications of tau\u2013role in human tauopathies and modeling in transgenic animals. Curr Drug Targets 5(6):503\u2013515. https:\/\/doi.org\/10.2174\/1389450043345236","journal-title":"Curr Drug Targets"},{"issue":"8","key":"1138_CR89","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1523\/JNEUROSCI.11-08-02453.1991","volume":"11","author":"MM Oblinger","year":"1991","unstructured":"Oblinger MM, Argasinski A, Wong J, Kosik KS (1991) Tau gene expression in rat sensory neurons during development and regeneration. J Neurosci 11(8):2453\u20132459. https:\/\/doi.org\/10.1523\/JNEUROSCI.11-08-02453.1991","journal-title":"J Neurosci"},{"issue":"5","key":"1138_CR90","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1073\/pnas.89.5.1983","volume":"89","author":"M Goedert","year":"1992","unstructured":"Goedert M, Spillantini MG, Crowther RA (1992) Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proc Natl Acad Sci U S A 89(5):1983\u20131987. https:\/\/doi.org\/10.1073\/pnas.89.5.1983","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1138_CR91","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/cne.903580209","volume":"358","author":"LJ Boyne","year":"1995","unstructured":"Boyne LJ, Tessler A, Murray M, Fischer I (1995) Distribution of Big tau in the central nervous system of the adult and developing rat. J Comp Neurol 358(2):279\u2013293. https:\/\/doi.org\/10.1002\/cne.903580209","journal-title":"J Comp Neurol"},{"issue":"8","key":"1138_CR92","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/eye.2015.100","volume":"29","author":"JA Ratnayaka","year":"2015","unstructured":"Ratnayaka JA, Serpell LC, Lotery AJ (2015) Dementia of the eye: the role of amyloid beta in retinal degeneration. Eye (Lond) 29(8):1013\u20131026. https:\/\/doi.org\/10.1038\/eye.2015.100","journal-title":"Eye (Lond)"},{"key":"1138_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","volume":"51","author":"E Vecino","year":"2016","unstructured":"Vecino E, Rodriguez FD, Ruzafa N, Pereiro X, Sharma SC (2016) Glia-neuron interactions in the mammalian retina. Prog Retin Eye Res 51:1\u201340. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.06.003","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"1138_CR94","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0197-4580(96)00010-3","volume":"17","author":"JC Blanks","year":"1996","unstructured":"Blanks JC, Torigoe Y, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer\u2019s disease. I. Ganglion cell loss in foveal\/parafoveal retina. Neurobiol Aging 17(3):377\u2013384. https:\/\/doi.org\/10.1016\/0197-4580(96)00010-3","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1138_CR95","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0197-4580(96)00009-7","volume":"17","author":"JC Blanks","year":"1996","unstructured":"Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer\u2019s disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging 17(3):385\u2013395. https:\/\/doi.org\/10.1016\/0197-4580(96)00009-7","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1138_CR96","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/ijms21030816","volume":"21","author":"E Salobrar-Garc\u00eda","year":"2020","unstructured":"Salobrar-Garc\u00eda E, Rodrigues-Neves AC, Ram\u00edrez AI, de Hoz R, Fern\u00e1ndez-Albarral JA, L\u00f3pez-Cuenca I, Ram\u00edrez JM, Ambr\u00f3sio AF, Salazar JJ (2020) Microglial activation in the retina of a triple-transgenic Alzheimer\u2019s disease mouse model (3xTg-AD). Int J Mol Sci 21(3):816. https:\/\/doi.org\/10.3390\/ijms21030816","journal-title":"Int J Mol Sci"},{"key":"1138_CR97","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jinorgbio.2015.07.009","volume":"152","author":"AI Pogue","year":"2015","unstructured":"Pogue AI, Dua P, Hill JM, Lukiw WJ (2015) Progressive inflammatory pathology in the retina of aluminum-fed 5xFAD transgenic mice. J Inorg Biochem 152:206\u2013209. https:\/\/doi.org\/10.1016\/j.jinorgbio.2015.07.009","journal-title":"J Inorg Biochem"},{"key":"1138_CR98","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.exer.2014.08.006","volume":"127","author":"MM Edwards","year":"2014","unstructured":"Edwards MM, Rodriguez JJ, Gutierrez-Lanza R, Yates J, Verkhratsky A, Lutty GA (2014) Retinal macroglia changes in a triple transgenic mouse model of Alzheimer\u2019s disease. Exp Eye Res 127:252\u2013260. https:\/\/doi.org\/10.1016\/j.exer.2014.08.006","journal-title":"Exp Eye Res"},{"issue":"6","key":"1138_CR99","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41419-018-0740-5","volume":"9","author":"A Grimaldi","year":"2018","unstructured":"Grimaldi A, Brighi C, Peruzzi G, Ragozzino D, Bonanni V, Limatola C, Ruocco G, Di Angelantonio S (2018) Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer\u2019s disease in the 3xTg-AD mouse model. Cell Death Dis 9(6):685. https:\/\/doi.org\/10.1038\/s41419-018-0740-5","journal-title":"Cell Death Dis"},{"issue":"8","key":"1138_CR100","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.neurobiolaging.2003.08.002","volume":"24","author":"SW Scheff","year":"2003","unstructured":"Scheff SW, Price DA (2003) Synaptic pathology in Alzheimer\u2019s disease: a review of ultrastructural studies. Neurobiol Aging 24(8):1029\u20131046. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2003.08.002","journal-title":"Neurobiol Aging"},{"issue":"5594","key":"1138_CR101","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer\u2019s disease is a synaptic failure. Science 298(5594):789\u2013791. https:\/\/doi.org\/10.1126\/science.1074069","journal-title":"Science"},{"issue":"1","key":"1138_CR102","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1172\/JCI20640","volume":"114","author":"RA Rissman","year":"2004","unstructured":"Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 114(1):121\u2013130. https:\/\/doi.org\/10.1172\/JCI20640","journal-title":"J Clin Invest"},{"issue":"7292","key":"1138_CR103","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/nature08890","volume":"464","author":"A de Calignon","year":"2010","unstructured":"de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, Spires-Jones TL, Hyman BT (2010) Caspase activation precedes and leads to tangles. Nature 464(7292):1201\u20131204. https:\/\/doi.org\/10.1038\/nature08890","journal-title":"Nature"},{"issue":"17","key":"1138_CR104","doi-asserted-by":"publisher","first-page":"10032","DOI":"10.1073\/pnas.1630428100","volume":"100","author":"TC Gamblin","year":"2003","unstructured":"Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 100(17):10032\u201310037. https:\/\/doi.org\/10.1073\/pnas.1630428100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"1138_CR105","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1523\/JNEUROSCI.1988-04.2004","volume":"24","author":"PM Horowitz","year":"2004","unstructured":"Horowitz PM, Patterson KR, Guillozet-Bongaarts AL, Reynolds MR, Carroll CA, Weintraub ST, Bennett DA, Cryns VL, Berry RW, Binder LI (2004) Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer\u2019s disease. J Neurosci 24(36):7895\u20137902. https:\/\/doi.org\/10.1523\/JNEUROSCI.1988-04.2004","journal-title":"J Neurosci"},{"issue":"4","key":"1138_CR106","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1046\/j.1460-9568.1999.00542.x","volume":"11","author":"K Von Kriegstein","year":"1999","unstructured":"Von Kriegstein K, Schmitz F, Link E, S\u00fcdhof TC (1999) Distribution of synaptic vesicle proteins in the mammalian retina identifies obligatory and facultative components of ribbon synapses. Eur J Neurosci 11(4):1335\u20131348. https:\/\/doi.org\/10.1046\/j.1460-9568.1999.00542.x","journal-title":"Eur J Neurosci"},{"issue":"4","key":"1138_CR107","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0928-4257(94)90088-4","volume":"88","author":"B Ullrich","year":"1994","unstructured":"Ullrich B, S\u00fcdhof TC (1994) Distribution of synaptic markers in the retina: implications for synaptic vesicle traffic in ribbon synapses. J Physiol Paris 88(4):249\u2013257. https:\/\/doi.org\/10.1016\/0928-4257(94)90088-4","journal-title":"J Physiol Paris"},{"issue":"1","key":"1138_CR108","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-018-0295-z","volume":"13","author":"H Zhu","year":"2018","unstructured":"Zhu H, Zhang W, Zhao Y, Shu X, Wang W, Wang D, Yang Y, He Z, Wang X, Ying Y (2018) GSK3\u03b2-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions. Mol Neurodegener 13(1):62. https:\/\/doi.org\/10.1186\/s13024-018-0295-z","journal-title":"Mol Neurodegener"},{"issue":"29","key":"1138_CR109","doi-asserted-by":"publisher","first-page":"10494","DOI":"10.1523\/JNEUROSCI.0148-11.2011","volume":"31","author":"PP Monnier","year":"2011","unstructured":"Monnier PP, D\u2019Onofrio PM, Magharious M, Hollander AC, Tassew N, Szydlowska K, Tymianski M, Koeberle PD (2011) Involvement of caspase-6 and caspase-8 in neuronal apoptosis and the regenerative failure of injured retinal ganglion cells. J Neurosci 31(29):10494\u201310505. https:\/\/doi.org\/10.1523\/JNEUROSCI.0148-11.2011","journal-title":"J Neurosci"},{"key":"1138_CR110","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/nature07767","volume":"457","author":"A Nikolaev","year":"2009","unstructured":"Nikolaev A, McLaughlin T, O\u2019Leary DD, Tessier-Lavigne M (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457:981\u2013989","journal-title":"Nature"},{"issue":"5","key":"1138_CR111","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu G-Q, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron 55(5):697\u2013711. https:\/\/doi.org\/10.1016\/j.neuron.2007.07.025","journal-title":"Neuron"},{"key":"1138_CR112","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1073\/pnas.1206171109","volume":"109","author":"MA Busche","year":"2012","unstructured":"Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, Konnerth A (2012) Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 109:8740\u20138745. https:\/\/doi.org\/10.1073\/pnas.1206171109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1138_CR113","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1017\/S0952523811000204","volume":"29","author":"E Gleason","year":"2012","unstructured":"Gleason E (2012) The influences of metabotropic receptor activation on cellular signaling and synaptic function in amacrine cells. Vis Neurosci 29(1):31\u201339. https:\/\/doi.org\/10.1017\/S0952523811000204","journal-title":"Vis Neurosci"},{"key":"1138_CR114","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fnins.2018.00441","volume":"12","author":"MJ P\u00e9rez","year":"2018","unstructured":"P\u00e9rez MJ, Jara C, Quintanilla RA (2018) Contribution of tau pathology to mitochondrial impairment in neurodegeneration. Front Neurosci 12:441. https:\/\/doi.org\/10.3389\/fnins.2018.00441","journal-title":"Front Neurosci"},{"key":"1138_CR115","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3389\/fnins.2017.00572","volume":"11","author":"A Kneynsberg","year":"2017","unstructured":"Kneynsberg A, Combs B, Christensen K, Morfini G, Kanaan NM (2017) Axonal degeneration in tauopathies: disease relevance and underlying mechanisms. Front Neurosci 11:572. https:\/\/doi.org\/10.3389\/fnins.2017.00572","journal-title":"Front Neurosci"},{"issue":"10","key":"1138_CR116","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.biocel.2009.04.013","volume":"41","author":"G Lenaers","year":"2009","unstructured":"Lenaers G, Reynier P, Elachouri G, Soukkarieh C, Olichon A, Belenguer P, Baricault L, Ducommun B, Hamel C, Delettre C (2009) OPA1 functions in mitochondria and dysfunctions in optic nerve. Int J Biochem Cell Biol 41(10):1866\u20131874. https:\/\/doi.org\/10.1016\/j.biocel.2009.04.013","journal-title":"Int J Biochem Cell Biol"},{"key":"1138_CR117","first-page":"1623","volume-title":"Myology Philadelphia","author":"S Di Mauro","year":"2004","unstructured":"Di Mauro S, Bonilla E (2004) Mitochondrial encephalomyopathies. In: Engel AG, Franzini-Armstrong C (eds) Myology Philadelphia, vol II. McGraw-Hill, Cambridge, pp 1623\u20131676"},{"key":"1138_CR118","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0091-679X(06)80004-X","volume":"80","author":"DM Kirby","year":"2007","unstructured":"Kirby DM, Thorburn DR, Turnbull DM, Taylor RW (2007) Biochemical assays of respiratory. Chain complex activity. Methods Cell Biol 80:93\u2013119. https:\/\/doi.org\/10.1016\/S0091-679X(06)80004-X","journal-title":"Methods Cell Biol"},{"issue":"4","key":"1138_CR119","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/gerona\/63.4.350","volume":"63","author":"PA Figueiredo","year":"2008","unstructured":"Figueiredo PA, Ferreira RM, Appell HJ, Duarte JA (2008) Age-induced morphological, biochemical, and functional alterations in isolatedmitochondria frommurine skeletal muscle. J Gerontol A Biol Sci Med Sci 63(4):350\u2013359. https:\/\/doi.org\/10.1093\/gerona\/63.4.350","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1138_CR120","doi-asserted-by":"publisher","DOI":"10.26124\/mitofit:190001.v6","author":"E Gnaiger","year":"2019","unstructured":"Gnaiger E, Aasander Frostner E, Abdul Karim N, Abdel-Rahman EA, Abumrad NA, AcunaCastroviejo D, Adiele RC et al (2019) Mitochondrial respiratory states and rates. MitoFit Preprint Arch. https:\/\/doi.org\/10.26124\/mitofit:190001.v6","journal-title":"MitoFit Preprint Arch"},{"issue":"1","key":"1138_CR121","doi-asserted-by":"publisher","first-page":"14038","DOI":"10.1038\/s41598-017-14420-x","volume":"7","author":"K-C Sonntag","year":"2017","unstructured":"Sonntag K-C, Ryu W-I, Amirault KM, Healy RA, Siegel AJ, McPhie DL, Forester B, Cohen BM (2017) Late-onset Alzheimer\u2019s disease is associated with inherent changes in bioenergetics profiles. Sci Rep 7(1):14038. https:\/\/doi.org\/10.1038\/s41598-017-14420-x","journal-title":"Sci Rep"},{"key":"1138_CR122","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3389\/fphys.2018.00921","volume":"9","author":"F Bajerski","year":"2018","unstructured":"Bajerski F, Stock J, Hanf B, Darienko T, Heine-Dobbernack E, Lorenz M, Naujox L, Keller ERJ, Schumacher HM, Friedl T, Eberth S, Mock H-P, Kniemeyer O, Overmann J (2018) ATP content and cell viability as indicators for cryostress across the diversity of life. Front Physiol 9:921. https:\/\/doi.org\/10.3389\/fphys.2018.00921","journal-title":"Front Physiol"},{"key":"1138_CR123","doi-asserted-by":"publisher","first-page":"2941783","DOI":"10.1155\/2018\/2941783","volume":"2018","author":"MA Cerquera-Jaramillo","year":"2018","unstructured":"Cerquera-Jaramillo MA, Nava-Mesa MO, Gonz\u00e1lez-Reyes RE, Tellez-Conti C, de-la Torre A (2018) Visual features in Alzheimer\u2019s disease: from basic mechanisms to clinical overview. Neural Plast 2018:2941783. https:\/\/doi.org\/10.1155\/2018\/2941783","journal-title":"Neural Plast"},{"key":"1138_CR124","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fnagi.2018.00188","volume":"10","author":"H Liao","year":"2018","unstructured":"Liao H, Zhu Z, Peng Y (2018) Potential utility of retinal imaging for Alzheimer\u2019s Disease: a review. Front Aging Neurosci 10:188. https:\/\/doi.org\/10.3389\/fnagi.2018.00188","journal-title":"Front Aging Neurosci"},{"issue":"Suppl 2","key":"1138_CR125","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40120-019-00173-4","volume":"8","author":"J Ngolab","year":"2019","unstructured":"Ngolab J, Honma P, Rissman RA (2019) Reflections on the utility of the retina as a biomarker for Alzheimer\u2019s Disease: a literature review. Neurol Ther 8(Suppl 2):57\u201372. https:\/\/doi.org\/10.1007\/s40120-019-00173-4","journal-title":"Neurol Ther"},{"issue":"3","key":"1138_CR126","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s12035-014-8733-6","volume":"51","author":"V Jindal","year":"2015","unstructured":"Jindal V (2015) Interconnection between brain and retinal neurodegenerations. Mol Neurobiol 51(3):885\u2013892. https:\/\/doi.org\/10.1007\/s12035-014-8733-6","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1138_CR127","doi-asserted-by":"publisher","first-page":"555","DOI":"10.4103\/ijo.IJO_999_19","volume":"68","author":"AK Singh","year":"2020","unstructured":"Singh AK, Verma S (2020) Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer\u2019s disease. Indian J Ophthalmol 68(4):555\u2013561. https:\/\/doi.org\/10.4103\/ijo.IJO_999_19","journal-title":"Indian J Ophthalmol"},{"key":"1138_CR128","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fneur.2016.00127","volume":"7","author":"A Masuzzo","year":"2016","unstructured":"Masuzzo A, Dinet V, Cavanagh C, Mascarelli F, Krantic S (2016) Amyloidosis in retinal neurodegenerative diseases. Front Neurol 7:127. https:\/\/doi.org\/10.3389\/fneur.2016.00127","journal-title":"Front Neurol"},{"issue":"3","key":"1138_CR129","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.optom.2018.07.001","volume":"12","author":"JA Fern\u00e1ndez-Albarral","year":"2019","unstructured":"Fern\u00e1ndez-Albarral JA, Salobrar-Garc\u00eda E, Mart\u00ednez-P\u00e1ramo R, Ram\u00edrez AI, de Hoz R, Ram\u00edrez JM, Salazar JJ (2019) Retinal glial changes in Alzheimer\u2019s disease\u2014a review. J Optom 12(3):198\u2013207. https:\/\/doi.org\/10.1016\/j.optom.2018.07.001","journal-title":"J Optom"},{"key":"1138_CR130","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fnagi.2017.00214","volume":"9","author":"AI Ramirez","year":"2017","unstructured":"Ramirez AI, de Hoz R, Salobrar-Garcia E, Salazar JJ, Rojas B, Ajoy D, L\u00f3pez-Cuenca I, Rojas P, Trivi\u00f1o A, Ram\u00edrez JM (2017) The role of microglia in retinal neurodegeneration: Alzheimer\u2019s Disease, parkinson, and glaucoma. Front Aging Neurosci 9:214. https:\/\/doi.org\/10.3389\/fnagi.2017.00214","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"1138_CR131","doi-asserted-by":"publisher","first-page":"e34724","DOI":"10.1371\/journal.pone.0034724","volume":"7","author":"ND Bull","year":"2012","unstructured":"Bull ND, Guidi A, Goedert M, Martin KR, Spillantini MG (2012) Reduced axonal transport and increased excitotoxic retinal ganglion cell degeneration in mice transgenic for human mutant P301S tau. PLoS ONE 7(4):e34724. https:\/\/doi.org\/10.1371\/journal.pone.0034724","journal-title":"PLoS ONE"},{"issue":"7","key":"1138_CR132","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1523\/JNEUROSCI.0774-15.2016","volume":"36","author":"N Mazzaro","year":"2016","unstructured":"Mazzaro N, Barini E, Spillantini MG, Goedert M, Medini P, Gasparini L (2016) Tau-driven neuronal and neurotrophic dysfunction in a mouse model of early tauopathy. J Neurosci 36(7):2086\u20132100. https:\/\/doi.org\/10.1523\/JNEUROSCI.0774-15.2016","journal-title":"J Neurosci"},{"issue":"1","key":"1138_CR133","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3129\/i07-185","volume":"43","author":"N Gupta","year":"2008","unstructured":"Gupta N, Fong J, Ang LC, Y\u00fccel YH (2008) Retinal tau pathology in human glaucomas. Can J Ophthalmol 43(1):53\u201360. https:\/\/doi.org\/10.3129\/i07-185","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"1138_CR134","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s10384-004-0156-x","volume":"49","author":"S Yoneda","year":"2005","unstructured":"Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H (2005) Vitreous fluid levels of beta-amyloid((1\u201342)) and tau in patients with retinal diseases. Jpn J Ophthalmol 49(2):106\u2013108. https:\/\/doi.org\/10.1007\/s10384-004-0156-x","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"1138_CR135","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s40478-020-01094-2","volume":"8","author":"RJ Bevan","year":"2020","unstructured":"Bevan RJ, Hughes TR, Williams PA, Good MA, Morgan BP, Morgan JE (2020) Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer\u2019s disease. Acta Neuropathol Commun 8(1):216. https:\/\/doi.org\/10.1186\/s40478-020-01094-2","journal-title":"Acta Neuropathol Commun"},{"key":"1138_CR136","doi-asserted-by":"crossref","unstructured":"Amadoro G, Latina V, Calissano P. A long story for a short peptide: therapeutic efficacy of a cleavage-specific tau antibody Neural Regeneration Research 2021 Vol:16, NRR-D-20-01040 (in press).","DOI":"10.4103\/1673-5374.313043"},{"issue":"8","key":"1138_CR137","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/aos.13472","volume":"95","author":"D Mahajan","year":"2017","unstructured":"Mahajan D, Votruba M (2017) Can the retina be used to diagnose and plot the progression of Alzheimer\u2019s disease? Acta Ophthalmol 95(8):768\u2013777. https:\/\/doi.org\/10.1111\/aos.13472","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"1138_CR138","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00401-018-1948-2","volume":"137","author":"C Cicognola","year":"2019","unstructured":"Cicognola C, Brinkmalm G, Wahlgren J, Portelius E, Gobom J, Cullen NC, Hansson O, Parnetti L, Constantinescu R, Wildsmith K, Chen HH, Beach TG, Lashley T, Zetterberg H, Blennow K, H\u00f6glund K (2019) Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer\u2019s disease. Acta Neuropathol 137(2):279\u2013296. https:\/\/doi.org\/10.1007\/s00401-018-1948-2","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1138_CR139","doi-asserted-by":"publisher","first-page":"165584","DOI":"10.1016\/j.bbadis.2019.165584","volume":"1866","author":"G Amadoro","year":"2020","unstructured":"Amadoro G, Latina V, Corsetti V, Calissano P (2020) N-terminal tau truncation in the pathogenesis of Alzheimer\u2019s Disease (AD): developing a novel diagnostic and therapeutic approach. Biochim Biophys Acta Mol Basis Dis 1866(3):165584. https:\/\/doi.org\/10.1016\/j.bbadis.2019.165584","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"s1","key":"1138_CR140","doi-asserted-by":"publisher","first-page":"S535","DOI":"10.3233\/JAD-179942","volume":"64","author":"P Novak","year":"2018","unstructured":"Novak P, Cehlar O, Skrabana R, Novak M (2018) Tau conformation as a target for disease-modifying therapy: the role of truncation. J Alzheimers Dis 64(s1):S535\u2013S546. https:\/\/doi.org\/10.3233\/JAD-179942","journal-title":"J Alzheimers Dis"},{"key":"1138_CR141","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fnins.2018.00798","volume":"12","author":"P Novak","year":"2018","unstructured":"Novak P, Kontsekova E, Zilka N, Novak M (2018) Ten years of tau-targeted immunotherapy: the path walked and the roads ahead. Front Neurosci 12:798. https:\/\/doi.org\/10.3389\/fnins.2018.00798","journal-title":"Front Neurosci"},{"key":"1138_CR142","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41541-018-0046-8","volume":"3","author":"A Bittar","year":"2018","unstructured":"Bittar A, Sengupta U, Kayed R (2018) Prospects for strain-specific immunotherapy in Alzheimer\u2019s disease and tauopathies. NPJ Vaccines 3:9. https:\/\/doi.org\/10.1038\/s41541-018-0046-8","journal-title":"NPJ Vaccines"},{"key":"1138_CR143","doi-asserted-by":"publisher","first-page":"104707","DOI":"10.1016\/j.nbd.2019.104707","volume":"134","author":"A Bittar","year":"2020","unstructured":"Bittar A, Bhatt N, Kayed R (2020) Advances and considerations in AD tau-targeted immunotherapy. Neurobiol Dis 134:104707. https:\/\/doi.org\/10.1016\/j.nbd.2019.104707","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1138_CR144","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.visres.2007.07.025","volume":"48","author":"JD Ding","year":"2008","unstructured":"Ding JD, Lin J, Mace BE, Herrmann R, Sullivan P, Bowes RC (2008) Targeting age-related macular degeneration with Alzheimer\u2019s disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model. Vis Res 48(3):339\u2013345. https:\/\/doi.org\/10.1016\/j.visres.2007.07.025","journal-title":"Vis Res"},{"key":"1138_CR145","doi-asserted-by":"publisher","first-page":"8850","DOI":"10.1073\/pnas.151261398","volume":"98","author":"RB De Mattos","year":"2001","unstructured":"De Mattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 98:8850\u20138855. https:\/\/doi.org\/10.1073\/pnas.151261398","journal-title":"Proc Natl Acad Sci USA"},{"issue":"536","key":"1138_CR146","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1126\/scitranslmed.aaw3210","volume":"12","author":"X Wang","year":"2020","unstructured":"Wang X, Lou N, Eberhardt A, Yang Y, Kusk P, Xu Q, F\u00f6rstera B, Peng S, Shi M, Ladr\u00f3n-de-Guevara A, Delle C, Sigurdsson B, Xavier ALR, Ert\u00fcrk A, Libby RT, Chen L, Thrane AS, Nedergaard M (2020) An ocular glymphatic clearance system removes \u03b2-amyloid from the rodent eye. Sci Transl Med 12(536):3210. https:\/\/doi.org\/10.1126\/scitranslmed.aaw3210","journal-title":"Sci Transl Med"},{"issue":"11","key":"1138_CR147","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1167\/iovs.17-22290","volume":"58","author":"E Mathieu","year":"2017","unstructured":"Mathieu E, Gupta N, Ahari A, Zhou X, Hanna J, Y\u00fccel YH (2017) Evidence for cerebrospinal fluid entry into the optic nerve via a glymphatic pathway. Invest Ophthalmol Vis Sci 58(11):4784\u20134791. https:\/\/doi.org\/10.1167\/iovs.17-22290","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1138_CR148","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1167\/iovs.19-26997","volume":"60","author":"HH Jacobsen","year":"2019","unstructured":"Jacobsen HH, Ringstad G, J\u00f8rstad \u00d8K, Moe MC, Sandell T, Eide PK (2019) The human visual pathway communicates directly with the subarachnoid space. Invest Ophthalmol Vis Sci 60(7):2773\u20132780. https:\/\/doi.org\/10.1167\/iovs.19-26997","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"1138_CR149","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1016\/j.neurobiolaging.2015.06.010","volume":"36","author":"KC Calaza","year":"2015","unstructured":"Calaza KC, Kam JH, Hogg C, Jeffery G (2015) Mitochondrial decline precedes phenotype development in the complement factor H mouse model of retinal degeneration but can be corrected by near infrared light. Neurobiol Aging 36(10):2869\u20132876. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.06.010","journal-title":"Neurobiol Aging"},{"issue":"11","key":"1138_CR150","doi-asserted-by":"publisher","first-page":"e13246","DOI":"10.1111\/acel.13246","volume":"19","author":"J Doustar","year":"2020","unstructured":"Doustar J, Rentsendorj A, Torbati T, Regis GC, Fuchs DT, Sheyn J, Mirzaei N, Graham SL, Shah PK, Mastali M, Van Eyk JE, Black KL, Gupta VK, Mirzaei M, Koronyo Y, Koronyo-Hamaoui M (2020) Parallels between retinal and brain pathology and response to immunotherapy in old, late-stage Alzheimer\u2019s disease mouse models. Aging Cell 19(11):e13246. https:\/\/doi.org\/10.1111\/acel.13246","journal-title":"Aging Cell"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-021-01138-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-021-01138-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-021-01138-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T20:09:41Z","timestamp":1671566981000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-021-01138-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1138"],"URL":"https:\/\/doi.org\/10.1186\/s40478-021-01138-1","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]},"assertion":[{"value":"17 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were complied with the ARRIVE guidelines and were carried out in accordance with the guidelines of the European Council Directive (2010\/63\/EU) and with the ethical standards of the Italian Ministry of Health (Authorization No. 524\/2017 PR; Authorization No. 1038-2020-PR).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All authors have seen and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"P.C. and G.A have intellectual property through CNR-EBRI regarding 12A12mAb.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}